GRI

1.1200.00%
WM

W. Marc Hertz

Co-Founder, CEO, President & Director

Dr. W. Marc Hertz, Ph.D. co-founded Multimeric Biotherapeutics, Inc. in 2008 and also served as its Chief Executive Officer. He is Co-Founder and President of GRI Bio, Inc. since April 20, 2023 and served as its Chief Executive Officer from April 20, 2023 and served as its Chairman of the Board and serves as its CEO since April 2023. He co-founded GRI Operations in 2009 and served as Chief Executive Officer and Chairperson of its board of directors since its inception. He serves as Director at GRI Bio, Inc. since April 20, 2023. He was Director and Chief Executive Officer of Vallon Pharmaceuticals, Inc. He moved to Pharmexa, where he worked on vaccine design, development and delivery. He rapidly rose to become a Senior Vice President of this 102 person company. He served as President and Chief Executive Officer of Pharmexa-Epimmune, Inc. and directed company strategy, business development, investor relations and participated in multiple rounds of public fundraising. He has experience in the field of biotechnology and immunology. He served as Managing Director of Birdrock Biotech Consultancy. He serves as the Chairman of Mutimeric Biotherapeutics. He was the Chairman and Director of Evozym Biologics, Inc. since June 24, 2014 to 2018. Dr. Hertz received his B.Sc. in Biology from Bowdoin College and his Ph.D. in Immunology and Microbiology from the University of Colorado Medical SchoolIn addition to his management positions, Dr. Hertz previously served on the boards of directors of GemVax AS from 2005 to 2009.

Positions